Literature DB >> 3370875

Interlocking intramedullary nailing in the treatment of tibial fractures. A report of 45 cases.

A Ekeland1, B O Thoresen, A Alho, K Strömsöe, G Follerås, A Haukebø.   

Abstract

Forty-five tibial shaft fractures in 43 patients were treated with the Grosse-Kempf interlocking intramedullary nail. The material was highly selected because 49% of the fractures were due to high-energy trauma and 62% were located at the diaphyseal-metaphyseal junctions. The median time to full weight-bearing was 30 days, and 44 fractures healed by bridging callus in a median of 16 weeks. There was one nonunion, one deep, and one superficial infection. The results of the clinical and radiologic evaluations were excellent in 29 fractures, good in 13, fair in two, and poor in one. Interlocking intramedullary nailing proved to be efficient for comminuted, segmental, and unstable tibial fractures, especially in patients with multiple injuries. Compared with conventional intramedullary nailing, the locking procedure increases the stability at the fracture site and extends the indication for nailing to fractures in the proximal and distal diaphyseal-metaphyseal junctions.

Entities:  

Mesh:

Year:  1988        PMID: 3370875

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Tibial shaft fractures treated with the AO unreamed tibial nail.

Authors:  S Kutty; M Farooq; D Murphy; C Kelliher; F Condon; J P McElwain
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

2.  Interlocking intramedullary nailing for the treatment of tibial fractures.

Authors:  J O'Beirne; P Seigne; J P McElwain
Journal:  Ir J Med Sci       Date:  1992-01       Impact factor: 1.568

3.  [Leg fractures with intact fibula: casting or intramedullary nailing? (comparative study of 60 cases)].

Authors:  Merouane Abouchane; Assia Fadili; Amine Belmoubarik; Yassir El Andaloussi; Mohammed Nechad
Journal:  Pan Afr Med J       Date:  2015-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.